Fig. 1.From: Successful treatment of refractory status asthmaticus with omalizumab: a case reportECMO and ventilation parameters. Arrows show ECMO initiation on day 1 and omalizumab administration on day 7. Tidal volume and minute ventilation significantly improved within 24Â h after omalizumab administration. ECMO was stopped on day 9 and the patient was extubated on day 11. ECMO, extracorporeal membrane oxygenation; Ppeak, peak inspiratory pressure; Vte expiratory tidal volumeBack to article page